Literature DB >> 25829474

The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists.

Laurent Fauchier1, Denis Angoulvant2, Gregory Y H Lip3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25829474     DOI： 10.1093/europace/euv088

Source DB:  PubMed          Journal:  Europace        ISSN： 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  4 in total

1.  SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience.

Authors:  Akash Kataruka; Xiaowen Kong; Brian Haymart; Eva Kline-Rogers; Steve Almany; Jay Kozlowski; Gregory D Krol; Scott Kaatz; Michael W McNamara; James B Froehlich; Geoffrey D Barnes
Journal:  Vasc Med       Date:  2017-02-01       Impact factor: 3.239

2.  Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention.

Authors:  Hanis Zulkifly; Gregory Y H Lip; Deirdre A Lane
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

3.  SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events.

Authors:  Fernando Pivatto Junior; Rafael Selbach Scheffel; Lucas Ries; Ricardo Roitman Wolkind; Roberta Marobin; Sabrina Sigal Barkan; Luís Carlos Amon; Andréia Biolo
Journal:  Arq Bras Cardiol       Date:  2017-04       Impact factor: 2.000

4.  Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.

Authors:  Jasper H A van Miert; Sarah Bos; Nic J G M Veeger; Karina Meijer
Journal:  PLoS One       Date:  2018-03-13       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.